CDRI possesses extensive experience in the research, development, scale-up, and commercial manufacturing of pharmaceutical substances, including on a contractual basis. 
These activities are conducted by highly trained personnel using modern equipment and advanced quality control systems.

The chemical production of API consists of two sections: 

- Cytostatics Workshop: Specialized area for manufacturing anticancer APIs

- General API Production: For non-cytotoxic pharmaceutical substances

All production zones conform to Class D cleanroom standards and are fully GMP-compliant.

The manufacturing infrastructure includes reactors ranging from 5 to 200 liters, enabling batch sizes from several grams to multiple kilograms. The facilities are also equipped with state-of-the-art filtration, mixing, and drying equipment.